Same Indication

Fluoxetine vs Nivolumab

Fluoxetine vs Nivolumab: Overview

This comparison examines the pharmacological differences between Fluoxetine and Nivolumab.

Mechanism of Action

Fluoxetine: Selective serotonin reuptake inhibitor (SSRI).

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Pharmacokinetics

Half-life: Fluoxetine — 1-3 days; Nivolumab — 27 days.

Chemical Properties

Molecular Formula: Fluoxetine — C17H18F3NO.

Molecular Weight: Fluoxetine — 309.3260 g/mol.

Type: Fluoxetine — Small molecule; Nivolumab — Antibody.